10-114843043-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020940.4(FHIP2A):āc.633G>Cā(p.Glu211Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,613,706 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_020940.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FHIP2A | NM_020940.4 | c.633G>C | p.Glu211Asp | missense_variant | 6/17 | ENST00000369248.9 | NP_065991.3 | |
FHIP2A | NM_001135051.2 | c.633G>C | p.Glu211Asp | missense_variant | 6/17 | NP_001128523.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHIP2A | ENST00000369248.9 | c.633G>C | p.Glu211Asp | missense_variant | 6/17 | 1 | NM_020940.4 | ENSP00000358251.4 | ||
FHIP2A | ENST00000369250.7 | c.633G>C | p.Glu211Asp | missense_variant | 6/17 | 1 | ENSP00000358253.3 | |||
FHIP2A | ENST00000710382.1 | c.729G>C | p.Glu243Asp | missense_variant | 6/17 | ENSP00000518239.1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251126Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135722
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461428Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 727044
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152278Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74456
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 17, 2024 | The c.633G>C (p.E211D) alteration is located in exon 6 (coding exon 6) of the FAM160B1 gene. This alteration results from a G to C substitution at nucleotide position 633, causing the glutamic acid (E) at amino acid position 211 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at